SELECT MEDICAL HOLDINGS CORP (SEM) Stock Fundamental Analysis

NYSE:SEM • US81619Q1058

14.82 USD
+0.04 (+0.27%)
At close: Feb 24, 2026
14.82 USD
0 (0%)
After Hours: 2/24/2026, 8:04:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SEM. SEM was compared to 101 industry peers in the Health Care Providers & Services industry. SEM has a medium profitability rating, but doesn't score so well on its financial health evaluation. SEM has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • SEM had positive earnings in the past year.
  • SEM had a positive operating cash flow in the past year.
  • Of the past 5 years SEM 4 years were profitable.
  • SEM had a positive operating cash flow in 4 of the past 5 years.
SEM Yearly Net Income VS EBIT VS OCF VS FCFSEM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • SEM has a better Return On Assets (3.72%) than 67.33% of its industry peers.
  • With a decent Return On Equity value of 12.53%, SEM is doing good in the industry, outperforming 78.22% of the companies in the same industry.
  • SEM's Return On Invested Capital of 4.34% is in line compared to the rest of the industry. SEM outperforms 49.51% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SEM is significantly below the industry average of 8.93%.
  • The 3 year average ROIC (3.10%) for SEM is below the current ROIC(4.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROIC 4.34%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
SEM Yearly ROA, ROE, ROICSEM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.08%, SEM is in the better half of the industry, outperforming 76.24% of the companies in the same industry.
  • SEM's Profit Margin has improved in the last couple of years.
  • SEM has a Operating Margin of 5.17%. This is in the better half of the industry: SEM outperforms 64.36% of its industry peers.
  • SEM's Operating Margin has declined in the last couple of years.
  • SEM has a worse Gross Margin (12.22%) than 71.29% of its industry peers.
  • In the last couple of years the Gross Margin of SEM has declined.
Industry RankSector Rank
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
SEM Yearly Profit, Operating, Gross MarginsSEM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
  • SEM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SEM Yearly Shares OutstandingSEM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SEM Yearly Total Debt VS Total AssetsSEM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • SEM has an Altman-Z score of 1.56. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.56, SEM perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
  • SEM has a debt to FCF ratio of 10.18. This is a negative value and a sign of low solvency as SEM would need 10.18 years to pay back of all of its debts.
  • SEM has a Debt to FCF ratio (10.18) which is in line with its industry peers.
  • A Debt/Equity ratio of 1.03 is on the high side and indicates that SEM has dependencies on debt financing.
  • SEM has a Debt to Equity ratio of 1.03. This is in the lower half of the industry: SEM underperforms 62.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Altman-Z 1.56
ROIC/WACC0.46
WACC9.51%
SEM Yearly LT Debt VS Equity VS FCFSEM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a worse Current ratio (1.09) than 62.38% of its industry peers.
  • A Quick Ratio of 1.09 indicates that SEM should not have too much problems paying its short term obligations.
  • SEM has a Quick ratio of 1.09. This is comparable to the rest of the industry: SEM outperforms 42.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SEM Yearly Current Assets VS Current LiabilitesSEM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

  • The earnings per share for SEM have decreased strongly by -30.30% in the last year.
  • The Earnings Per Share has been decreasing by -9.36% on average over the past years.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.41%

3.2 Future

  • SEM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.64% yearly.
  • The Revenue is expected to grow by 4.74% on average over the next years.
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEM Yearly Revenue VS EstimatesSEM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SEM Yearly EPS VS EstimatesSEM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2 2.5

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 12.89, which indicates a correct valuation of SEM.
  • Based on the Price/Earnings ratio, SEM is valued cheaper than 86.14% of the companies in the same industry.
  • SEM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.98.
  • With a Price/Forward Earnings ratio of 11.19, the valuation of SEM can be described as very reasonable.
  • SEM's Price/Forward Earnings ratio is rather cheap when compared to the industry. SEM is cheaper than 86.14% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SEM to the average of the S&P500 Index (28.01), we can say SEM is valued rather cheaply.
Industry RankSector Rank
PE 12.89
Fwd PE 11.19
SEM Price Earnings VS Forward Price EarningsSEM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SEM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SEM is cheaper than 76.24% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a rather cheap valuation: SEM is cheaper than 81.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.54
EV/EBITDA 8.48
SEM Per share dataSEM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • SEM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as SEM's earnings are expected to grow with 21.64% in the coming years.
PEG (NY)0.85
PEG (5Y)N/A
EPS Next 2Y15.26%
EPS Next 3Y21.64%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.69%, SEM has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, SEM pays a better dividend. On top of this SEM pays more dividend than 89.11% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SEM has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

  • SEM has paid a dividend for at least 10 years, which is a reliable track record.
  • SEM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
SEM Yearly Dividends per shareSEM Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • SEM pays out 18.80% of its income as dividend. This is a sustainable payout ratio.
DP18.8%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
SEM Yearly Income VS Free CF VS DividendSEM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
SEM Dividend Payout.SEM Dividend Payout, showing the Payout Ratio.SEM Dividend Payout.PayoutRetained Earnings

SELECT MEDICAL HOLDINGS CORP

NYSE:SEM (2/24/2026, 8:04:00 PM)

After market: 14.82 0 (0%)

14.82

+0.04 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners82.91%
Inst Owner Change-3.76%
Ins Owners11.06%
Ins Owner Change0.26%
Market Cap1.84B
Revenue(TTM)N/A
Net Income(TTM)211.72M
Analysts77.78
Price Target17.88 (20.65%)
Short Float %3.94%
Short Ratio4.91
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP18.8%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-02
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.01%
Min EPS beat(2)30.21%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)-20.63%
Min EPS beat(4)-158.51%
Max EPS beat(4)49.82%
EPS beat(8)4
Avg EPS beat(8)-7.1%
EPS beat(12)7
Avg EPS beat(12)-2.62%
EPS beat(16)9
Avg EPS beat(16)-3.49%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)1.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.63%
Min Revenue beat(4)-11.07%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.53%
Revenue beat(12)7
Avg Revenue beat(12)-0.91%
Revenue beat(16)10
Avg Revenue beat(16)5.68%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 12.89
Fwd PE 11.19
P/S 0.35
P/FCF 10.54
P/OCF 4.5
P/B 1.09
P/tB N/A
EV/EBITDA 8.48
EPS(TTM)1.15
EY7.76%
EPS(NY)1.32
Fwd EY8.93%
FCF(TTM)1.41
FCFY9.48%
OCF(TTM)3.29
OCFY22.21%
SpS41.89
BVpS13.64
TBVpS-6.02
PEG (NY)0.85
PEG (5Y)N/A
Graham Number18.79
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 12.53%
ROCE 5.65%
ROIC 4.34%
ROICexc 4.39%
ROICexgc 9.14%
OM 5.17%
PM (TTM) 4.08%
GM 12.22%
FCFM 3.35%
ROA(3y)3%
ROA(5y)3.51%
ROE(3y)15.18%
ROE(5y)20.83%
ROIC(3y)3.1%
ROIC(5y)4.82%
ROICexc(3y)3.14%
ROICexc(5y)4.99%
ROICexgc(3y)6.3%
ROICexgc(5y)12.6%
ROCE(3y)4.06%
ROCE(5y)6.32%
ROICexgc growth 3Y-27.06%
ROICexgc growth 5Y-9.65%
ROICexc growth 3Y-20.88%
ROICexc growth 5Y-5.51%
OM growth 3Y-23.39%
OM growth 5Y-9.78%
PM growth 3Y-13.32%
PM growth 5Y9.18%
GM growth 3Y-6.23%
GM growth 5Y-3.9%
F-Score5
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF 10.18
Debt/EBITDA 4.17
Cap/Depr 155.87%
Cap/Sales 4.5%
Interest Coverage 2.17
Cash Conversion 97.47%
Profit Quality 82.19%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.56
F-Score5
WACC9.51%
ROIC/WACC0.46
Cap/Depr(3y)103.75%
Cap/Depr(5y)94.3%
Cap/Sales(3y)4.39%
Cap/Sales(5y)3.74%
Profit Quality(3y)115.02%
Profit Quality(5y)150.87%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y15.13%
EPS Next 2Y15.26%
EPS Next 3Y21.64%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.41%
Revenue Next Year4.33%
Revenue Next 2Y4.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.4%
EBIT growth 3Y-27.83%
EBIT growth 5Y-10.68%
EBIT Next Year-15.98%
EBIT Next 3Y-2.09%
EBIT Next 5Y0.36%
FCF growth 1Y-9.04%
FCF growth 3Y10.24%
FCF growth 5Y0.52%
OCF growth 1Y-1.83%
OCF growth 3Y8.88%
OCF growth 5Y3.07%

SELECT MEDICAL HOLDINGS CORP / SEM FAQ

Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SEM.


What is the valuation status for SEM stock?

ChartMill assigns a valuation rating of 8 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Undervalued.


Can you provide the profitability details for SELECT MEDICAL HOLDINGS CORP?

SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.


What are the PE and PB ratios of SELECT MEDICAL HOLDINGS CORP (SEM) stock?

The Price/Earnings (PE) ratio for SELECT MEDICAL HOLDINGS CORP (SEM) is 12.89 and the Price/Book (PB) ratio is 1.09.


Can you provide the financial health for SEM stock?

The financial health rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 2 / 10.